• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

AI's Impact on Oncology Cancer Drug Development

Wednesday, June 05, 2024
Breakout Session
Oncology
26B
The world of cancer drug development is experiencing a seismic shift, thanks to the transformative power of AI. This visionary session delves into the realm of AI technologies that are reshaping the landscape of cancer drug discovery, paving the way for more effective, targeted, and efficient treatments. Join us for an illuminating discussion that brings together leading experts, AI researchers, and pharmaceutical visionaries to explore the latest breakthroughs in AI-driven cancer drug development.
Moderator
Wyatt McDonnell, PhD
CEO & Co-founder
Infinimmune
Speakers
Jakob Dupont, MD
Executive Partner
Sofinnova Investments
Kamni Vijay, PhD
CEO
Enable Medicine
Andrei Georgescu, PhD
CEO & Founder
Vivodyne
Daniel Silva Manzano, PhD
CEO & Co-Founder
Monod Bio
Abe Heifets, PhD
CEO & Co-Founder
Atomwise
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS